Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
1 of 2 |
A nurse prepares a syringe before injecting a patient with the new HIV prevention drug lenacapavir at the ART clinic at Mbarara City Council Health Center IV in western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
License this photo
By LAURA UNGAR
Updated 5:41 PM EST, November 2, 2026
Leer en español
Share
Facebook
Copy Link copied
Print
Email
X
LinkedIn
Bluesky
Flipboard
Pinterest
Reddit
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
The announcement was made on Monday morning by the manufacturer and organizations that helped to speed up development of the medication, called lenacapavir.
The drug is expected to cost $40 a year per person in the countries where it will be available, the…